Oversold is understatement of the year. I know of plenty of bios where a trial has not moved on and there was not even a blimp on the share price. In fact I know one company where trials did move on and not even ASX Ann was given and shareholders did not even care. We still have so many trials under way that this over selling is almost manic.
Ann: GBM Agile Update, page-105
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)